AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2019

Nov 26, 2019

35146_dirs_2019-11-26_0bdb9a03-e2f7-4791-98b5-6533a3fcdab9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2019-11-22

Reporting Person: Rubinstein Samuel (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-22	SSKN Common Stock	A	14228	—	Acquired	52098	Direct

Footnotes

F1: Represents Restricted Stock Units issued to the recipient, in lieu of a portion of his Board compensation, on November 22, 2019 at the closing price of $2.46. The Restricted Stock Units will vest 100%, in equal quarterly installments, over a 12 month period.

F2: Includes 26,570 fully vested Restricted Stock Units granted on June 8, 2018 and previously reported on Table II.